New Lancet Commission calls for urgent action to tackle Europe’s rising liver disease burden Every day in Europe, nearly 780 people die from cirrhosis or liver cancer — conditions that are largely preventable. A major new report from the EASL–Lancet Commission on Liver Health in Europe warns that…
Consistent and permanent abstinence from alcohol can lead to the regression of existing liver-related complications, even in cases of advanced alcohol-related cirrhosis. This is shown by an international multicenter study led by MedUni Vienna, which was recently published in the renowned Journal …
We’re proud to share a major milestone for the A-TANGO Consortium: the latest publication is now available in the Journal of Hepatology: Highlights of this important publication: This study in global cohorts of patients with acute decompensation of cirrhosis aimed to develop a new organ failure …
Geneva, 18 February 2026 – The European Association for the Study of the Liver (EASL) has called on WHO Member States to support a landmark World Health Organization (WHO) draft resolution, “Steatotic Liver Disease – A Missing Piece in the Global Noncommunicable Disease Response” . EASL welcomes …
EASL invites you to watch this on-demand webinar bringing together leading experts from across Europe to explore why early detection of chronic liver disease must become a priority in primary care. Through real-world experiences, the panel discusses how primary care professionals can integrate mo…
PRESS RELEASE 3 December 2025 On behalf of the European Health Alliance on Alcohol (EHHA), the European Association for the Study of the Liver (EASL) welcomes the European Parliament’s decision to safeguard consumers by endorsing clear and accurate “reduced-alcohol” labelling. Brussels – The Euro…
The DECISION consortium has just published a fundamental study in the Journal of Hepatology on immune mechanisms predicting outcomes in patients with acutely decompensated cirrhosis (ADC). By analysing whole-blood RNA-sequencing (RNA-seq) data from over 1,200+ patients, researchers identified mal…
In recent years, the Journal of Hepatology has witnessed a marked increase in the number of Letters to the Editor submitted for consideration. While we continue to value thoughtful academic dialogue and constructive critique of published work, we have observed that a substantial proportion of the…
Amsterdam, May 2, 2024 – New evidence reveals global underassessment and undertreatment of chronic hepatitis B (HBV), especially among women and Asian minorities in the West, a new study in the Journal of Hepatology, published…
The European Association for the Study of the Liver (EASL) is launching a Call for Applications for the position of Editor-in-Chief of its flagship journal, Journal of Hepatology, for a 5-year term beginning on January 1st, 2025.The Journal of Hepatology, EASL’s flagships journal, has been in…
